|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.260 EUR | +3.40% |
|
+2.40% | +15.14% |
| 05-04 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
Company Valuation: MEDICLIN AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 186.2 | 171 | 130.2 | 115 | 175.8 | 202.4 | - | - |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 15.14% | - | - |
| Enterprise Value (EV) | 186.2 | 171 | 130.2 | 115 | 175.8 | 202.4 | 202.4 | 202.4 |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 15.14% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | 1.02x | 0.82x | 0.66x | 0.52x | 0.71x | 0.71x | 0.63x | 0.56x |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.28x | 0.24x | 0.18x | 0.15x | 0.22x | 0.26x | 0.25x | 0.25x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.26x | 0.25x | 0.25x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 1.77x | 1.76x | 1.75x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 3.26x | 3.24x | 3.23x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | - | - | - | - | 1.08% | 0.94% | 0.94% | 0.94% |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 673.1 | 704.7 | 730.1 | 748.8 | 784.5 | 787.5 | 803.2 | 819.3 |
| EBITDA 1 | 85.22 | 90.92 | 98.73 | 103.8 | 115.6 | 114.3 | 115.3 | 115.6 |
| EBIT 1 | 11.56 | 19.52 | 12.72 | 53.49 | 55.36 | 62.11 | 62.47 | 62.72 |
| Net income 1 | 1.461 | 9.441 | -10.78 | 24.84 | 25.49 | 36.66 | 38.2 | 40.12 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 3.920 | 3.600 | 2.740 | 2.420 | 3.700 | 4.260 | 4.260 | 4.260 |
| Nbr of stocks (in thousands) | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | - | - |
| Announcement Date | 3/30/22 | 3/31/23 | 3/27/24 | 3/28/25 | 3/27/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | 0.94% | 230M | ||
| 32.02x | 3.06x | 13.78x | 1.36% | 17.93B | ||
| 66.41x | 5.23x | 35.43x | 0.27% | 13.15B | ||
| 21.22x | 3.02x | 10.78x | 1.99% | 11.58B | ||
| 18.33x | 2.12x | 9.95x | 0.68% | 11.2B | ||
| 24.45x | 1.96x | 16.33x | 0.15% | 10.03B | ||
| 18.53x | 2.7x | 11.11x | 4.31% | 8.92B | ||
| 52.3x | 6.92x | 28.86x | 0.12% | 7.44B | ||
| 32.29x | 0.88x | 7.33x | 2% | 6.8B | ||
| 12.33x | 1.08x | 7.1x | 2.11% | 6.69B | ||
| Average | 30.88x | 3.00x | 15.63x | 1.39% | 9.4B | |
| Weighted average by Cap. | 32.00x | 3.10x | 16.26x | 1.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MED Stock
- Valuation MEDICLIN AG
Select your edition
All financial news and data tailored to specific country editions
















